FIELD: medicine.
SUBSTANCE: invention refers to medicine and can be used for radiotherapy in combined treatment of soft tissue sarcoma. Method involves preoperative stereotactic radiation therapy in mode of 5 fractions with a single dose on the planned tumor volume – 5 Gy, single dose on the clinical tumor volume – 7 Gy with an inward position to the tumor center from macroscopically defined tumor edges per 1 cm, and 25–35 postoperative days – postoperative 3D-conformal radiation therapy in 25 fractions of 2 Gy for fraction per entire clinical volume of tumor.
EFFECT: invention allows reducing a risk of dissemination of the tumor process during the operation.
1 cl, 8 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING SOFT TISSUE SARCOMAS OF EXTREMITIES | 2023 |
|
RU2818463C1 |
| METHOD OF RADIATION THERAPY OF PATIENTS WITH LOCOREGIONAL RECURRENCES OF PROSTATE CANCER AFTER RADICAL PROSTATECTOMY AND PRESENCE OF SINGLE REMOTE METASTASES | 2019 |
|
RU2712009C1 |
| METHOD FOR ADJUVANT ADAPTIVE STEREOTACTIC RADIATION THERAPY IN THE TREATMENT OF PRIMARY MALIGNANT GLIAL BRAIN TUMORS | 2021 |
|
RU2759405C1 |
| METHOD OF CHEMORADIATION THERAPY OF LOW-LOCATED TUMOURS OF RECTUM AND ANAL CANAL | 2009 |
|
RU2400268C1 |
| METHOD OF STEREOTACTIC RADIATION THERAPY OF LOCALIZED KIDNEY CANCER IN INOPERABLE PATIENTS | 2022 |
|
RU2808011C1 |
| METHOD OF TREATING SQUAMOUS ORAL CANCER AND PHARYNX | 2019 |
|
RU2715550C2 |
| METHOD FOR COMBINED TREATMENT OF STAGE III NON-SMALL CELL LUNG CANCER USING THERMOCHEMI-RADIOTHERAPY | 2017 |
|
RU2654612C1 |
| METHOD FOR TREATING METASTATIC CEREBRAL AFFECTION | 2015 |
|
RU2599195C1 |
| METHOD OF RADIATION THERAPY OF PATIENTS WITH SINGLE AND MULTIPLE RECURRENT PROSTATE CANCER IN AREA OF REGIONAL LYMPH NODES AFTER RADICAL PROSTATECTOMY | 2020 |
|
RU2738793C1 |
| METHOD OF RADIATION THERAPY OF PATIENTS WITH RECURRENT PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY WITH METASTASES IN REGIONAL AND RETROPERITONEAL LYMPH NODES | 2019 |
|
RU2711620C1 |
